ABOUT BEXSERO
The person(s) depicted are models used for illustrative purposes only.
What is BEXSERO?
BEXSERO is a vaccine designed to help protect you or your child against invasive meningococcal disease caused by Neisseria meningitidis group B.6,7*
BEXSERO works by helping the body produce its own protection, or antibodies, against meningococcal group B bacteria.6,7
As with all vaccines, protection cannot be guaranteed for every vaccinated person.6,7
*BEXSERO is indicated for vaccination of individuals from 2 months of age and older.6,7
What protection does BEXSERO provide?
BEXSERO helps protect against invasive meningococcal group B disease only.6,7
A separate vaccine is required to help protect against meningococcal groups A, C, W and Y.4,5
There is currently no single vaccine that protects against all meningococcal groups.4,5
Funding
BEXSERO is part of the National Immunisation Schedule.4,5
Funded access includes:4,5,11†
- Infants and children aged under 5 years
- Eligible adolescents and young adults aged 13–25 years in specified close-living situations
- Individuals aged 5 years and older with certain medical conditions
Funding criteria may change over time. Refer to the Pharmaceutical Schedule or speak with your healthcare professional for current eligibility requirements.
†BEXSERO is indicated for vaccination of individuals from 2 months of age and older.6,7
Vaccination Schedule
More than one dose of BEXSERO is required to be fully vaccinated against meningococcal group B disease.6,7‡
The number of doses depends on age at first dose and risk factors. Adolescents and adults aged 13-25 years should receive 2 doses of BEXSERO, administered with an interval of at least one month.6,7
Your healthcare professional will administer BEXSERO by injection into your upper arm, or in children it can be given into the thigh muscle.6,7
Talk to your doctor, nurse or pharmacist about the vaccination schedule that may be appropriate for you or your family.
‡Vaccination may not protect all vaccine recipients.6,7
BEXSERO Dosing Guide6,7*
| Age at first dose | Primary immunisation | Interval between primary doses | Booster |
| 2-11 months** | 2doses | ≥2months | 1 dosein the second year of life |
| 12-23 months** | 2doses | ≥2months | 1 dose12-23 months post primary series |
| Children >2 years, Adolescents and adults# | 2doses | ≥1months | Need not established† |
*The number of funded doses may differ. Refer to the Pharmaceutical Schedule for full funding criteria. BEXSERO can be administered at the same time as certain other vaccines, in separate syringes and at separate injection sites.4-7,11
**The safety profile and efficacy of BEXSERO in infants less than 8 weeks of age has not yet been established.6
#The safety profile and efficacy of BEXSERO in individuals above 50 years of age have not been established.6
†1 booster dose may be considered in individuals at continued risk of exposure to meningococcal disease, based on official recommendations.6
What should I expect after vaccination?7
All medicines can have side effects. If you or your child experience side effects, most of them are minor and temporary. However, some side effects may need medical attention.7
Very common side effects in adolescents (from 11 years of age) and adults include:6,7
- Pain at the injection site
- Headache
- Muscle pain
- Joint pain
- Feeling generally unwell
- Nausea
Talk to your healthcare professional if you have any questions or concerns following vaccination.
Fully vaccinated = full prescribed course completed6
